Stay updated on Nivolumab Plus Bevacizumab in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Bevacizumab in GBM Clinical Trial page.

Latest updates to the Nivolumab Plus Bevacizumab in GBM Clinical Trial page
- Check5 days agoChange DetectedA new Revision: v3.7.0 is added, and several older study documents and contributor references (e.g., Informed Consent Form, Study Protocol, Case Comprehensive Cancer Center, David Peereboom) were removed from the page.SummaryDifference22%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision number was updated to v3.6.6, indicating a routine maintenance release rather than substantive content changes.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Informed Consent Form and Study Protocol/Statistical Analysis Plan as downloadable documents and included related resource links on the study page. These additions provide direct access to official protocol and consent materials.SummaryDifference69%

- Check48 days agoChange DetectedThe page's revision tag was updated to v3.6.5, replacing the previous v3.6.4, indicating a minor update to the study record documentation.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 on the page, indicating a minor update to the page version. No changes to trial details or content are indicated by this revision.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision: v3.6.3 replaces v3.6.2 on the page. This is a minor update to the study documentation version displayed on the page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Bevacizumab in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Bevacizumab in GBM Clinical Trial page.